|

GFH375 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Genfleet Therapeutics (Shanghai) Inc.1

Indications

  • KRAS G12D Mutations1
  • Advanced Solid Tumors1
  • Cancer1

Other1 trial

A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.